N-Isobutyl-3-methoxyaniline | 31084-56-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: N-Isobutyl-3-methoxyaniline
• 英文别名: 3-methoxy-N-isobutylaniline；(3-methoxyphenyl)isobutylamine；N-Isobutyl-m-methoxyanilin；3-methoxy-N-(2-methylpropyl)aniline
• CAS: 31084-56-7
• 化学式: C₁₁H₁₇NO
• mdl: MFCD11147077
• 分子量: 179.262
• InChiKey: CAFZMKMGDSLQQY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  21.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-Isobutyl-3-methoxyaniline 在 zinc(II) chloride sodium carbonate 作用下， 以 乙醇 、 xylene 为溶剂， 反应 20.0h， 生成 N-Isobutyl-2-allyl-3-methoxyaniline
  参考文献：
  名称：

  Lewis acid-promoted 3-aza-Cope rearrangement of N-alkyl-N-allylanilines

  摘要：

  The 3-aza-Cope rearrangement of N-alkyl-N-allylaniline substrates, which required 250-degrees-C to proceed thermally, was promoted by Lewis acid reagents at 111-140-degrees-C. Systematic studies of this reaction were performed to examine a number of reaction variables such as concentration, the stoichiometry of the Lewis acid with the substrate, the optimum temperature for rearrangement, and the type of Lewis acid reagent. Of the many Lewis acids investigated, ZnCl2 (140-degrees-C) and Et2O.BF3 (111-degrees-C) were the most generally successful reagents for promoting the aromatic 3-aza-Cope rearrangement. With respect to substrate variation, the presence of a methoxy substituent para to the N-allyl group slowed the reaction slightly, while a meta substituent accelerated the rate of [3,3] rearrangement and produced moderate site selectivity on the aromatic ring. Lewis acid-promoted rearrangement of an unsymmetrically substituted allyl moiety resulted in [3,3] sigmatropic rearrangement to give the 1-hexen-3-yl substituent on the aromatic ring. Overall, both ZnCl2 and Et2O.BF3 were shown to efficiently accelerate the regiospecific 3-aza-Cope rearrangement of N-alkyl-N-allylanilines for the purpose of forming a carbon-carbon bond between a secondary alkyl substituent and an aromatic ring.

  DOI：

  10.1021/jo00071a018
• 作为产物：
  描述：

  3-碘苯甲醚 、 异丁胺 在 potassium phosphate 、 copper(l) iodide 、 N-((1-oxy-pyridin-2-yl)methyl)oxalamic acid 作用下， 以 水 、 二甲基亚砜 为溶剂， 以75%的产率得到N-Isobutyl-3-methoxyaniline
  参考文献：
  名称：

  N-(1-Oxy-2-picolyl)草氨酸作为铜催化的室温下芳基碘胺化的有效配体

  摘要：

  N-(1-Oxy-pyridin-2-ylmethyl) 草氨酸被确定为室温下 CuI 催化的芳基卤化物胺化的有效配体。在我们的催化系统中，环状仲胺、伯胺、氨基酸和氨的 N-芳基化以中等至优异的产率和高官能团耐受性进行。

  DOI：

  10.1002/ejoc.201500279

文献信息

• SULFONAMIDE COMPOUNDS AND THEIR USE IN THE MODULATION RETINOID-RELATED ORPHAN RECEPTOR
  申请人：Glaxo Group Limited

  公开号：US20140243362A1

  公开（公告）日：2014-08-28

  The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators of formula (I), processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by RORγ wherein R 1 to R 7 are as defined in claim 35.

  本发明涉及一种新型的与视黄醇相关孤儿受体γ（RORγ）调节剂，其化学式为（I），以及用于制备这些调节剂的方法，含有这些调节剂的药物组合物，以及它们在治疗由RORγ介导的炎症、代谢和自身免疫疾病中的应用，其中R1至R7如权利要求35所定义。
• [EN] SULFONAMIDE COMPOUNDS AND THEIR USE IN THE MODULATION RETINOID - RELATED ORPHAN RECEPTOR<br/>[FR] COMPOSÉS DE SULFONAMIDE ET LEUR UTILISATION DANS LA MODULATION DU RÉCEPTEUR ORPHELIN APPARENTÉ AU RÉCEPTEUR DES RÉTINOÏDES
  申请人：GLAXO GROUP LTD

  公开号：WO2013045431A1

  公开（公告）日：2013-04-04

  The present invention is directed to novel retinoid-related orphan receptor gamma (RORy) modulators of formula (I), processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by RORy wherein R1 to R7 are as defined in claim 1.

  本发明涉及一种新型的与视黄醇相关孤儿受体γ（RORγ）调节剂，其化学式为（I），以及制备这些调节剂的方法、含有这些调节剂的药物组合物，以及它们在治疗由RORγ介导的炎症性、代谢性和自身免疫性疾病中的应用，其中R1至R7如权利要求1所定义。
• INDAZOLE SULFONAMIDE DERIVATIVES AS INVERSE AGONISTS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA (T))
  申请人：GALDERMA RESEARCH & DEVELOPMENT

  公开号：US20170342062A1

  公开（公告）日：2017-11-30

  Indazole sulfonamide derivatives of formula (I), the pharmaceutically acceptable addition salts thereof, the hydrates and/or solvates thereof, and the use of same as inverse agonists of retinoid-related orphan receptor gamma RORγt are described. Pharmaceutical compositions including such compounds, as well as the use thereof for the topical and/or oral treatment of RORγt receptor-mediated inflammatory diseases, in particular acne, psoriasis and/or atopic dermatitis are also described.

  本发明涉及式(I)的吲唑磺胺衍生物，其药学上可接受的加盐物，其水合物和/或溶剂合物，以及将其用作视黄醇相关孤儿受体伽玛RORγt的逆向激动剂的用途。还描述了包括这些化合物的药物组合物，以及将其用于治疗RORγt受体介导的炎症性疾病，特别是痤疮、银屑病和/或特应性皮炎的局部和/或口服治疗。
• [EN] PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLIC ACID COMPOUNDS AND DERIVATIVES THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION DE COMPOSÉS ACIDE 1H-PYRAZOLE-5-CARBOXYLIQUE N-SUBSTITUÉS ET DE LEURS DÉRIVÉS
  申请人：BASF SE

  公开号：WO2014184343A1

  公开（公告）日：2014-11-20

  The present invention relates to a process for preparing N-substituted 1 H-pyrazole-5-carboxylic acid compounds of the formula l-A and derivatives thereof, in particular the corresponding carbonylchloride compounds (acid chlorides). It also relates to the use of these acid chlorides for preparing anthranilamide derivatives that are useful pesticides. in which the variables are as defined in the claims and the specification comprising the steps of i) reacting a compound of the formula (II) with a base selected from combinations of a magnesium-organic compound having a carbon bound magnesium and a secondary amine and magnesium amides of secondary amines in the presence of a lithium halide, where the base is used in an amount sufficient to achieve at least 80 % deprotonation of the compound of formula (II); and subjecting the product obtained in step (i) to a carboxylation by reacting it with carbon dioxide or a carbon dioxide equivalent, to obtain a magnesium salt of the compound of formula (l-A) and optionally aqueous workup to obtain the compound of the formula (l-A) as a free acid.

  本发明涉及一种制备N-取代1H-吡唑-5-羧酸化合物及其衍生物的方法，特别是相应的羰基氯化合物（酸氯化物）。还涉及使用这些酸氯化物来制备对昆虫有用的蒽醯胺衍生物杀虫剂。其中变量如索赔中所定义和规范中包括以下步骤：i）将式（II）的化合物与选择自具有碳键镁的有机镁化合物和次级胺以及次级胺的镁酰胺的组合的碱在锂卤化物存在下反应，其中所述碱的用量足以实现式（II）的化合物至少80%的脱质子化；并将在步骤（i）中获得的产物经羧化反应，与二氧化碳或二氧化碳等效物反应，以获得化合物的镁盐（l-A）和可选的水工艺处理以获得化合物的自由酸形式（l-A）。
• Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR γ (T))
  申请人：GALDERMA RESEARCH & DEVELOPMENT

  公开号：US10246440B2

  公开（公告）日：2019-04-02

  Indazole sulfonamide derivatives of formula (I), the pharmaceutically acceptable addition salts thereof, the hydrates and/or solvates thereof, and the use of same as inverse agonists of retinoid-related orphan receptor gamma RORγt are described. Pharmaceutical compositions including such compounds, as well as the use thereof for the topical and/or oral treatment of RORγt receptor-mediated inflammatory diseases, in particular acne, psoriasis and/or atopic dermatitis are also described.

  本发明描述了式(I)的吲唑磺酰胺衍生物、其药学上可接受的加成盐、其水合物和/或溶剂，以及其作为维甲酸相关孤儿受体γ RORγt的逆激动剂的用途。 此外，还介绍了包括此类化合物的药物组合物，以及将其用于局部和/或口服治疗 RORγt 受体介导的炎症性疾病，特别是痤疮、牛皮癣和/或特应性皮炎的方法。